Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Marc Samama

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Archives of Internal Medicine|October 24, 2002
Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulantCharles Marc Samama, Muriel Vray, Jeanne Barré, et al.
Thrombosis and Haemostasis|July 29, 2010
Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrelClemence Hindy-François, Christilla Bachelot-Loza, Bernard Le Bonniec, et al.
Critical Care (London, England)|October 6, 2012
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practiceThibaut Desmettre, Emilie Dehours, Charles-Marc Samama, et al.
Anesthesiology|November 2, 2011
Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit modelAnne Godier, Anastasia Miclot, Bernard Le Bonniec, et al.
Anaesthesia, Critical Care & Pain Medicine|December 4, 2016
The structure, organisation and perioperative management of ambulatory surgery and anaesthesia in France: Methodology of the SFAR-OPERA studyPierre Albaladejo, Frédéric Aubrun, Charles-Marc Samama, et al.
Thrombosis and Haemostasis|March 13, 2015
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxabanGeorges Jourdi, Virginie Siguret, Anne Céline Martin, et al.
Thrombosis Journal|May 19, 2017
Perioperative management of patients on direct oral anticoagulantsVirginie Dubois, Anne-Sophie Dincq, Jonathan Douxfils, et al.
European Journal of Anaesthesiology|September 10, 2015
The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro studyAnne-Céline Martin, Célia Berndt, Leyla Calmette, et al.
The Lancet. Haematology|December 9, 2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trialIsabelle Mahé, Céline Chapelle, Philippe Girard, et al.
COPD|October 31, 2018
Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung CancerSuela Demiri, Christine Lorut, Antoine Rabbat, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Archives of Internal Medicine|October 24, 2002
Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulantCharles Marc Samama, Muriel Vray, Jeanne Barré, et al.
Thrombosis and Haemostasis|July 29, 2010
Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrelClemence Hindy-François, Christilla Bachelot-Loza, Bernard Le Bonniec, et al.
Critical Care (London, England)|October 6, 2012
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practiceThibaut Desmettre, Emilie Dehours, Charles-Marc Samama, et al.
Anesthesiology|November 2, 2011
Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit modelAnne Godier, Anastasia Miclot, Bernard Le Bonniec, et al.
Anaesthesia, Critical Care & Pain Medicine|December 4, 2016
The structure, organisation and perioperative management of ambulatory surgery and anaesthesia in France: Methodology of the SFAR-OPERA studyPierre Albaladejo, Frédéric Aubrun, Charles-Marc Samama, et al.
Thrombosis and Haemostasis|March 13, 2015
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxabanGeorges Jourdi, Virginie Siguret, Anne Céline Martin, et al.
Thrombosis Journal|May 19, 2017
Perioperative management of patients on direct oral anticoagulantsVirginie Dubois, Anne-Sophie Dincq, Jonathan Douxfils, et al.
European Journal of Anaesthesiology|September 10, 2015
The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro studyAnne-Céline Martin, Célia Berndt, Leyla Calmette, et al.
The Lancet. Haematology|December 9, 2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trialIsabelle Mahé, Céline Chapelle, Philippe Girard, et al.
COPD|October 31, 2018
Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung CancerSuela Demiri, Christine Lorut, Antoine Rabbat, et al.
Pageof 10